Younglimwon Soft Lab Co., Ltd.

As of June 30, 2026, Younglimwon Soft Lab Co., Ltd. carries a market capitalization of 41.39B, placing it among publicly traded companies globally. Its enterprise value stands at 39.32B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Younglimwon Soft Lab Co., Ltd.'s next confirmed earnings release is scheduled for November 12, 2026.

As of June 30, 2026, Younglimwon Soft Lab Co., Ltd. has 8.13M shares outstanding.

As of June 30, 2026, Younglimwon Soft Lab Co., Ltd. trades at a trailing price-to-earnings ratio of 16.42. The price-to-sales ratio is 0.48, and the price-to-book ratio stands at 0.78.

As of June 30, 2026, Younglimwon Soft Lab Co., Ltd. trades at an EV/EBITDA multiple of 9.47 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.46 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 12.91 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 39.32B versus a market cap of 41.39B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Younglimwon Soft Lab Co., Ltd. maintains a current ratio of 2.39, meaning it holds 2.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 43.53, indicating elevated leverage, while an interest coverage ratio of 23.41 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Younglimwon Soft Lab Co., Ltd. posted a return on equity (ROE) of 4.86, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 3.90 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 2.89, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 3.91, useful for judging operating efficiency across full business cycles. The company generates approximately 205.47M in revenue per employee across its workforce of 416.50, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Younglimwon Soft Lab Co., Ltd. recorded 320.04M in income tax expense. That works out to an effective tax rate of 11.43, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 2.80B, leaving 2.50B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, Younglimwon Soft Lab Co., Ltd.'s stock has declined approximately 32.20% over the past 52 weeks. The 50-day moving average sits at 4,547.60, while the 200-day moving average is 5,570.20.

Over the twelve months ended June 30, 2026, Younglimwon Soft Lab Co., Ltd. generated 85.58B in revenue and converted that into 2.50B in net income, yielding earnings per share of 307.55. EBITDA reached 4.15B, while operating income came in at 3.05B.

As of June 30, 2026, Younglimwon Soft Lab Co., Ltd. holds 25.15B in cash and equivalents against 23.02B in total debt, resulting in a net debt position of 11.67B. Total book value stands at 52.82B, with working capital of 27.20B providing operational flexibility.

Younglimwon Soft Lab Co., Ltd. produced 7.60B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -19.26B in capital expenditures, free cash flow totaled -11.66B - equivalent to -1,446.07 per share.

Over the twelve months ended June 30, 2026, Younglimwon Soft Lab Co., Ltd. posted a gross margin of 41.11, reflecting its pricing power and cost economics. The operating margin of 3.56 and net profit margin of 2.92 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Younglimwon Soft Lab Co., Ltd. paid dividends of - - per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -28.41: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -23.36, meaning Younglimwon Soft Lab Co., Ltd. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, Younglimwon Soft Lab Co., Ltd. has an Altman Z-Score of 2.37, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.